节点文献

A群脑膜炎球菌多糖结合疫苗的制备及其稳定性考察

Preparation and Stability Study of Group A Meningococcal Polysaccharide Conjugate Vaccine

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 熊慧玲周家富潭柯邹澄川许蓉华李松罗素吴认艰王蓉付慧兰

【Author】 Xiong Hui-ling,Zhou Jia-fu,Tan Ke,et al. Chengdu Institute of Biological Products,Chengdu 610063,China.

【机构】 成都生物制品研究所成都生物制品研究所 成都610063成都610063成都610063

【摘要】 目的 制备安全、有效的A群脑膜炎球菌多糖结合疫苗。方法 将A群脑膜炎球菌多糖以已二酰肼作为多糖和蛋白之间的连接子与精制破伤风类毒素结合 ,形成A群脑膜炎球菌多糖结合疫苗原液 ,加保护剂后冻干制成A群脑膜炎球菌多糖结合疫苗 ,检测其生化、生物学特性和安全性 ,并考察制品的稳定性。结果 结合疫苗各项检测结果达到质量控制标准 ,制品放置 2年后仍保持稳定。结论 A群脑膜炎球菌多糖结合疫苗制备工艺是可行和稳定的

【Abstract】 Objective To prepare safe and valid Group A Meningococcal polysaccharide conjugate vaccine. Methods Group A Meningococcal polysaccharide reacted with adipic acid hydrazide(ADH) and bunded to purified tetanus toxioid, then got the original liquid of meningococcal polysaccharide conjugate vaccine , protectant were added in it then freeze-dried.At last,we examined vaccine’s biochemistrical and biological character and security and investigated its stability. Results Conjugate vaccine is enough good to fit the standard of quality control and still kept its stability after two years. Conclusion The technics of preparation of Group A Meningococcal polyscaccharide conjugate vaccine is stable and fessible.

  • 【文献出处】 预防医学情报杂志 ,Journal of Preventive Medicine Information , 编辑部邮箱 ,2004年02期
  • 【分类号】R392-33
  • 【被引频次】3
  • 【下载频次】227
节点文献中: 

本文链接的文献网络图示:

本文的引文网络